Cargando…
Label-Free Mass Spectrometry-Based Quantification of Linker Histone H1 Variants in Clinical Samples
Epigenetic aberrations have been recognized as important contributors to cancer onset and development, and increasing evidence suggests that linker histone H1 variants may serve as biomarkers useful for patient stratification, as well as play an important role as drivers in cancer. Although traditio...
Autores principales: | Noberini, Roberta, Morales Torres, Cristina, Savoia, Evelyn Oliva, Brandini, Stefania, Jodice, Maria Giovanna, Bertalot, Giovanni, Bonizzi, Giuseppina, Capra, Maria, Diaferia, Giuseppe, Scaffidi, Paola, Bonaldi, Tiziana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582528/ https://www.ncbi.nlm.nih.gov/pubmed/33020374 http://dx.doi.org/10.3390/ijms21197330 |
Ejemplares similares
-
Spatial epi-proteomics enabled by histone post-translational modification analysis from low-abundance clinical samples
por: Noberini, Roberta, et al.
Publicado: (2021) -
Profiling of Epigenetic Features in Clinical Samples Reveals Novel Widespread Changes in Cancer
por: Noberini, Roberta, et al.
Publicado: (2019) -
Mass spectrometry‐based characterization of histones in clinical samples: applications, progress, and challenges
por: Noberini, Roberta, et al.
Publicado: (2021) -
Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach
por: Noberini, Roberta, et al.
Publicado: (2016) -
Pathology Tissue-quantitative Mass Spectrometry Analysis to Profile Histone Post-translational Modification Patterns in Patient Samples
por: Noberini, Roberta, et al.
Publicado: (2016)